Details for Patent: 8,865,690
✉ Email this page to a colleague
Which drugs does patent 8,865,690 protect, and when does it expire?
Patent 8,865,690 protects WINLEVI and is included in one NDA.
This patent has seventeen patent family members in fourteen countries.
Summary for Patent: 8,865,690
Title: | 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
Abstract: | 17.alpha.,21-Dihydroxypregna-4,9(11)-diene-3,20-dione and 17.alpha.,21-dihydroxypregna-4-ene-3,20-dione 17 and/or 21 esters thereof having remarkable antiandrogenic activity, and the processes for the preparation thereof. |
Inventor(s): | Ajani; Mauro (Lainate, IT), Moro; Luigi (Cairate, IT) |
Assignee: | Cosmo Dermatos Srl (Lainate (MI), IT) |
Application Number: | 14/103,707 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 8,865,690
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm | WINLEVI | clascoterone | CREAM;TOPICAL | 213433-001 | Aug 26, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING ACNE VULGARIS WITH TOPICALLY APPLIED CORTEXOLONE 17A-PROPIONATE | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,865,690
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 289318 | ⤷ Try a Trial | |||
Australia | 2002328956 | ⤷ Try a Trial | |||
Canada | 2454675 | ⤷ Try a Trial | |||
China | 1246328 | ⤷ Try a Trial | |||
China | 1541220 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |